Wound Care Formulations
Wound Healing
CommercialActive
Key Facts
About MediCell Technologies
MediCell Technologies is a private, commercial-stage biotech company bridging the gap between advanced stem cell science and commercial applications. Its core strategy involves generating near-term revenue through the sale of clinically-proven, patent-protected cosmeceutical products while building a service-based revenue stream and foundational IP for future therapeutic development. The company is led by a seasoned executive team with deep expertise in stem cell research, clinical practice, and biotech finance, positioning it to capitalize on the growing markets for advanced skincare and regenerative medicine.
View full company profileTherapeutic Areas
Other Wound Healing Drugs
| Drug | Company | Phase |
|---|---|---|
| CYWC628 | FibroBiologics | Discovery |
| BXT-25 | BioXyTran | Preclinical |
| Advanced Wound Care Program | Ionic Pharmaceuticals | Research |
| SBX 1977 | Stramsen Biotech | Early-stage Clinical |
| StroMel™ (Planned) | Akan Biosciences | Planned |
| MRG-001 | MedRegen | Phase 2 |
| CordLining Stem Cell Therapy | CellResearchCorp | Phase 1 |
| ABCcolla® Collagen Matrix | ACRO Biomedical | Commercial |